Meet the Editorial Board
In 1999, Fabio Coppedè joined Prof. Lucia Migliore's group at the Department of Human and Environmental Sciences of the University of Pisa for the preparation of his Master Degree thesis in Biological Sciences. In that period he worked on oxidative DNA damage and genetic susceptibility to Parkinson's disease. In 2000, he was the recipient of a "Mobility Grant" from the University of Pisa and had the opportunity to conduct research as academic visitor in Prof. David Collier laboratory, at the Department of Psychiatry of the King's College London, for the completion of his Master Degree research project.
Back to Italy, he continued his research career in Prof. Lucia Migliore group working respectively as trainee (2001) (2002) and Ph.D. student (2002 Ph.D. student ( -2005 . In those years, he still carried out research on DNA damage in neurodegenerative diseases, but focused his main research activity on the contribution of folate metabolism to cancer and maternal risk of birth of a child with 1) Investigating the contribution of one-carbon metabolism and epigenetic factors to the risk of cancer, neurodegenerative diseases, autoimmune disorders and cardiovascular diseases. The group is currently addressing this topic by means of several approaches, including the analysis of plasma values of methyl donor compounds (folate, homocysteine and related B vitamins), genotyping for polymorphisms of genes involved in folate metabolism, and the analysis of the methylation status of selected genes in cell cultures, blood DNA, or cells obtained from the patient's affected tissues. Furthermore, we are developing high-throughput methods for the analysis of DNA methylation, and we are interested in the application of artificial intelligence systems for the understanding of complex interactions among genetic, environmental and epigenetic factors in those diseases.
2) Addressing the maternal risk of having a child with Down syndrome related to folate metabolism. This topic is investigated by means of several approaches, including measurements of plasma biomarkers of one-carbon metabolism; genotyping for
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polymorphisms in folate metabolizing genes; analysis of chromosome damage and malsegregation events in mothers of Down syndrome individuals; application of artificial neural networks in order to understand how predictive could be all the above biomarkers to asses the risk for a young woman to give birth to a child with Down syndrome; literature meta-analysis approaches.
3) Addressing the genotoxic and epigenetic properties of nano sized materials. This topic is investigated by means of a panel of in vitro approaches to evaluate the genetic and epigenetic changes induced in cell cultures by nanoparticles and nanomaterials.
Research Products:
Dr Coppedè is author of almost 70 peer reviewed articles (indexed in PubMed, Scopus and/or ISI web of knowledge databases), 15 book chapters, 90 meeting abstracts, and several divulgative articles in Italian journals. According to Scopus (Author ID: 8972617800) he received over 1680 citations and has a current h-index = 24. 
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